Business Context and Reporting Period
Company: The Clorox Company
Filing Type: Form 8-K (Current Report)
Date of Report: October 1, 2014
Event: Entry into a new material definitive credit agreement and termination of a prior agreement.
Key Financial Metrics and Liquidity
- New Credit Facility: $1,100,000,000 five-year unsecured revolving credit agreement.
- Purpose: General corporate purposes.
- Lenders: Citibank, N.A., JPMorgan Chase Bank, N.A., and Wells Fargo Bank, National Association (as administrative agents).
- Interest Rate Options: Base rate plus margin or LIBOR plus margin, dependent on the Company's credit rating.
- Fees: Quarterly facility fee and letter of credit fees, varying by credit rating.
- Financial Covenants: The agreement contains only one financial covenant: a consolidated leverage ratio.
- Revenue/Profit/Cash Flow: The filing text does not provide specific values for revenue, profit, cash flow, or margins.
Material Changes Versus Prior Period
- Termination of Prior Agreement: The Company terminated its existing credit agreement dated May 4, 2012, which was due to mature on May 4, 2017.
- Termination Costs: No material termination fees or penalties were incurred.
- Structure Change: Replaced a 2012 facility with a new 2014 facility of $1.1 billion.
Outlook, Risks, and Contingencies
- Covenants: The agreement includes customary affirmative and negative covenants, including restrictions on liens, consolidations, mergers, and asset sales.
- Events of Default: Includes nonpayment, covenant defaults, breaches of representations, bankruptcy, insolvency, cross defaults, and change of control.
- Related Party Transactions: Certain lenders have pre-existing relationships with the Company, including participation in prior credit facilities, share repurchase programs, bond offerings, and derivative transactions.
- Management Commentary: The filing does not provide specific forward-looking guidance or management commentary beyond the terms of the agreement.
Key Facts for Investor Verification
- Verify the specific terms of the consolidated leverage ratio covenant in the attached Credit Agreement (Exhibit 10.1).
- Confirm the current credit rating of The Clorox Company to determine applicable interest rate margins and facility fees.
- Review the full text of Exhibit 10.1 for detailed restrictions on asset sales and mergers.
- Assess the impact of the new facility on the Company's overall debt maturity profile compared to the terminated 2012 agreement.